Invention Grant
- Patent Title: Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
-
Application No.: US13006795Application Date: 2011-01-14
-
Publication No.: US08574850B2Publication Date: 2013-11-05
- Inventor: Ardythe L. Morrow , Guillermo Ruiz-Palacios , David S. Newburg
- Applicant: Ardythe L. Morrow , Guillermo Ruiz-Palacios , David S. Newburg
- Applicant Address: MX Mexico US MA Boston US OH Cincinnati
- Assignee: Instituto Nacional de Ciencias Medicas Y Nutricion,The General Hospital Corporation,Children's Hospital Medical Center
- Current Assignee: Instituto Nacional de Ciencias Medicas Y Nutricion,The General Hospital Corporation,Children's Hospital Medical Center
- Current Assignee Address: MX Mexico US MA Boston US OH Cincinnati
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
Public/Granted literature
- US20110177035A1 USE OF SECRETOR, LEWIS AND SIALYL ANTIGEN LEVELS IN CLINICAL SAMPLES AS PREDICTORS OF RISK FOR DISEASE Public/Granted day:2011-07-21
Information query
IPC分类:
